Related Experiment Video
Updated: Apr 28, 2026

Membrane Potential Dye Imaging of Ventromedial Hypothalamus Neurons From Adult Mice to Study Glucose Sensing
Published on: November 27, 2013
Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose
Benedetta Russo1, Giorgia D'Addato2, Giulia Salvatore3
1Unit of Endocrinology and Diabetology, Isola Tiberina-Gemelli Isola Hospital, 00186 Rome, Italy.
Abstract:
Retinal neurodegeneration (RN), an early marker of diabetic retinopathy (DR), is closely associated with Müller glia cells (MGs) in diabetic subjects. MGs play a pivotal role in maintaining retinal homeostasis, integrity, and metabolic support and respond to diabetic stress. In lower vertebrates, MGs have a strong regenerative response and can completely repair the retina after injuries. However, this ability diminishes as organisms become more complex. The aim of this study was to investigate the gliotic response and reprogramming potential of the human Müller cell line MIO-M1 cultured in normoglycemic (5 mM glucose, NG) and hyperglycemic (25 mM glucose, HG) conditions and then exposed to sustained high-glucose and glucose fluctuation (GF) treatments to mimic the human diabetic conditions. The results showed that NG MIO-M1 cells exhibited a dynamic activation to sustained high-glucose and GF treatments by increasing GFAP and Vimentin expression together, indicative of gliotic response. Increased expression of SHH and SOX2 were also observed, foreshadowing reprogramming potential. Conversely, HG MIO-M1 cells showed increased levels of the indexes reported above and adaptation/desensitization to sustained high-glucose and GF treatments. These findings indicate that MIO-M1 cells exhibit a differential response under various glucose treatments, which is dependent on the metabolic environment. The in vitro model used in this study, based on a well-established cell line, enables the exploration of how these responses occur in a controlled, reproducible system and the identification of strategies to promote neurogenesis over neurodegeneration. These findings contribute to the understanding of MGs responses under diabetic conditions, which may have implications for future therapeutic approaches to diabetes-associated retinal neurodegeneration.
Insights
Human Müller glia cells (MGs) show distinct responses to diabetic conditions, with potential for reprogramming. Understanding these reactions is key to developing therapies for diabetic retinopathy and retinal neurodegeneration.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss, with retinal neurodegeneration (RN) as an early indicator.
- Müller glia cells (MGs) are crucial for retinal health and respond to diabetic stress, exhibiting regenerative potential in lower vertebrates but reduced capacity in complex organisms.
- The human Müller cell line (MIO-M1) serves as a model to study gliotic responses and reprogramming potential under diabetic conditions.
Purpose of the Study:
- To investigate the gliotic response and reprogramming potential of human MIO-M1 cells under various glucose conditions mimicking diabetes.
- To explore how sustained high-glucose and glucose fluctuation treatments affect MIO-M1 cell behavior.
- To understand the differential responses of MIO-M1 cells based on their metabolic environment.
Main Methods:
- Culturing human MIO-M1 cells in normoglycemic (5 mM glucose) and hyperglycemic (25 mM glucose) conditions.
- Exposing cells to sustained high-glucose and glucose fluctuation treatments to simulate diabetic environments.
- Analyzing the expression of glial fibrillary acidic protein (GFAP), Vimentin, SHH, and SOX2 to assess gliotic response and reprogramming potential.
Main Results:
- MIO-M1 cells in normoglycemic conditions showed dynamic activation (gliotic response) with increased GFAP and Vimentin expression when exposed to high-glucose and glucose fluctuation.
- Increased SHH and SOX2 expression were observed in normoglycemic cells, suggesting reprogramming potential.
- Hyperglycemic MIO-M1 cells demonstrated adaptation/desensitization to sustained high-glucose and glucose fluctuation treatments.
Conclusions:
- Human MIO-M1 cells exhibit differential responses to glucose treatments, influenced by the metabolic environment.
- The study provides an in vitro model for exploring Müller glia cell responses in diabetes-associated retinal neurodegeneration.
- Findings may inform future therapeutic strategies aimed at promoting neurogenesis and mitigating neurodegeneration in diabetic eyes.
More Related Videos
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

